Señales en vivo de BTTX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 14:09):

Stats
Volumen de hoy	114 410
Volumen promedio	5.87M
Capitalización de mercado	626 929
EPS	$0 ( 2024-04-04 )
Próxima fecha de ganancias	( $-0.120 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0100
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-09	Perry David P	Buy	839 895	Common Stock
2024-01-09	Perry David P	Buy	1 471 453	Common Stock
2023-12-18	Perry David P	Buy	3 750	Common Stock
2023-12-18	Carmona Richard H	Buy	3 750	Common Stock
2023-12-18	Lavizzo-mourey Risa J	Buy	3 750	Common Stock

INSIDER POWER
99.11
Last 98 transactions
Buy: 15 006 415 \| Sell: 72 086

Better Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas
CPSH	0.952
RGF	0.952
PHCF	0.935
CLEU	0.934
UONEK	0.926
WKSP	0.925
UONE	0.92
AZYO	0.919
QNRX	0.917
PRTS	0.917

10 Correlaciones Más Negativas
DXPE	-0.957
GRCL	-0.952
ADMS	-0.944
MIRO	-0.941
MNMD	-0.941
JYNT	-0.94
FMIV	-0.936
SWBI	-0.936
GIFI	-0.936
PATI	-0.932

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Better Therapeutics, Inc. Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-2.73M (0.00 %)
EPS:	$-1.690

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-2.73M (0.00 %)
EPS:	$-1.690

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.709

FY	2020
Ingresos:	$8 000.00
Beneficio Bruto:	$-674 000 (-8 425.00 %)
EPS:	$-0.334

Financial Reports:

No articles found.

Better Therapeutics, Inc.

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.

Actualizaciones en tiempo real para Better Therapeutics, Inc. [BTTX]

Upcoming Earnings Alert